Clinical Trial Update: Evolocumab Added to Statin Therapy in Symptomatic Intracranial Atherosclerotic Stenosis (EAST-ICAS) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating evolocumab added to statin therapy in patients with symptomatic intracranial atherosclerotic stenosis is listed as ongoing/unknown st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke
• Symptomatic Intracranial Atherosclerotic Stenosis

Drugs mentioned

• Evolocumab (evolocumab)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Stroke Patients With Symptomatic Intracranial Atherosclerotic Stenosis | Phase 3 | Status: UNKNOWN